YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the better value opportunity right now? Let's…
Sandoz Group (SWX:SDZ) has moved back into focus after partnering with mAbxience on a proposed emicizumab biosimilar for hemophilia A, adding another rare disease project to its global generics and biosimilars portfolio. Recent announcemen…
mAbxience and Sandoz have entered into a collaboration agreement combining mAbxience's development and manufacturing expertise with Sandoz's global commercial capabilities for a proposed emicizumab biosimilar candidate. Emicizumab biosimil…
Investors interested in Medical - Drugs stocks are likely familiar with Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a cl…
[The company sign of Sandoz Switzerland AG - an international pharmaceutical company] * Swiss drug maker Sandoz (SDZNY [https://seekingalpha.com/symbol/SDZNY]) aims to more than double net sales from 2025 levels by 2035 and achieve a core…
For Immediate Release Chicago, IL – August 31, 2026 – Today, Zacks Equity Research discusses Amphastar Pharmaceuticals AMPH, Sandoz SDZNY and Viatris VTRS. Industry: Generic Drugs Link: https://www.zacks.com/commentary/2981324/3-generic-dr…
Recent earnings across the generic drug industry point to a mixed but generally resilient operating environment. Reported sales at several manufacturers were affected by lower contributions from older high-value products, continued price e…
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial arrangements, the total invoiced amo…
This article first appeared on GuruFocus. Net Sales: Increased by 5% at constant currencies in H1 2026, reaching US$5.8 billion, up from US$5.2 billion in H1 2025. Biosimilar Sales: Grew by 20% in H1, accelerating to 22% in Q2, and reached…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Sandoz Group (SWX:SDZ) has agreed US settlements that resolve long running investigations into generic drug pricing. The company ha…
Investors interested in Medical - Drugs stocks are likely familiar with United Therapeutics (UTHR) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking for undervalued stocks? Let…
Blister packs of medications by Sandoz, arranged as a Swiss cross. The Basel-based pharma group has reached two settlements in the United States (Fabrice COFFRINI) Swiss pharmaceutical group Sandoz on Monday announced two amicable settleme…
This article first appeared on GuruFocus. President Donald Trump has said generic drug manufacturers must move production to the United States or face a 100% import tariff from August 2028, with the levy set to rise to 200% in August 2029.…
Liquidia Corporation LQDA is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (P…
ZOFINGEN, SWITZERLAND - July 16, 2026 (NEWMEDIAWIRE) - Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, has appointed Eduardo Montanha as Chief Operating Of…
BASEL, SWITZERLAND - June 22, 2026 (NEWMEDIAWIRE) - Sandoz (SIX:SDZ / OTCQX:SDZNY), the global leader in affordable medicines, will host its 2026 capital markets day for investors and analysts: The formal part of the event, webcast live, w…
Embecta Corp. PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today…
Generic medicines remain one of the most important pillars of global healthcare, but the industry's growth drivers are changing. While traditional small-molecule generics continue to account for substantial prescription volumes, intense co…
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and United Therapeutics (UTHR). But which of these two stocks presents investors with the better value oppo…
Sandoz Group AG Sponsored ADR (SDZNY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces i…
Investors interested in stocks from the Medical - Drugs sector have probably already heard of USANA Health Sciences (USNA) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the better value op…
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best small-cap value stocks to buy. On April 24, H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) and a $55 price target.Is Harmony Bi…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Q1 2026 trading update and why it matters for Sandoz shares Sandoz Group (SWX:SDZ) has just repor…
Amneal Pharmaceuticals AMRX is leaning into complex products and biosimilars to drive steadier growth. The 2026 setup centers on an elevated launch cadence in Affordable Medicines and expanding injectables capabilities, with 2027 positione…
Amneal Pharmaceuticals AMRX is leaning into a playbook that can work in multiple market backdrops. The company is pairing steady demand in generics with higher-value opportunities in complex injectables, biosimilars, and branded Specialty…
Company Logo The global dermal mycosis market is experiencing steady growth, driven by increased incidence of fungal skin infections, advancements in antifungal therapies, and rising tropical populations. Common fungal pathogens include Tr…
We just covered the 14 Best Low Risk High Growth Stocks to Buy Right Now and Novartis AG (NYSE:NVS) ranks 7th on this list. Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transfor…
Company Logo The Middle East and Africa biosimilars market is poised for strong growth due to patent expiries, increased chronic disease prevalence, and supportive regulations. High demand for affordable biologics, especially for oncologic…
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks is more attractive to value investors? We'll need to ta…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. If you are wondering whether Sandoz Group is still reasonably priced after its strong run or if the…
Sandoz Group AG Sponsored ADR (SDZNY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces i…
Investors interested in Medical - Drugs stocks are likely familiar with Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks offers value investors a better bang for their bu…
Alvotech Asupplemental long‑form earnings release providing additional operational details and business update for Q4 2025 and the full year is available at: https://investors.alvotech.com/earnings-calendar The supplemental document is pro…
Samsung Bioepis office in Songdo, Incheon, Republic of Korea The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and commercialization in global…
Investors with an interest in Medical - Drugs stocks have likely encountered both Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks offers value investors a better bang fo…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The fair value estimate for Sandoz Group has shifted from CHF 58.42 to about CHF 62.57, bringing…